InvestorsHub Logo
Followers 75
Posts 9167
Boards Moderated 0
Alias Born 04/25/2002

Re: rickstereo3333 post# 33989

Monday, 12/05/2022 10:10:24 PM

Monday, December 05, 2022 10:10:24 PM

Post# of 36581
Rick.... RVVTF is following the same FDA EUA path by redefining their primary endpoints with hopes that the new endpoints will help them with gaining EUA. The jury is out on whether that will be successful or not. That little trick did not work for Relief though.

The similarity between the two drugs is they are both trying to slip under the COVID therapeutic wire, and they are both tiny, foreign entity penny stocks. Unfortunately the FDA is tends to favor USA based pharmaceuticals, and/or Big Pharm in general. So RVVTF does have a shot at it. I'm just not optimistic based on the FDA track record. Nor am I bearish though.

What you are omitting is the Relief drug (aviptadil) was essentially stolen and received full EUA in India. It's being used there with patients now. Also, the NIH / FDA trial was with the IV version of the drug, not inhaled. You are missing a ton of DD. Not that it matters.